loadpatents
name:-0.00089001655578613
name:-0.0026030540466309
name:-0.00035595893859863
Weavers; Rex T. Patent Filings

Weavers; Rex T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Weavers; Rex T..The latest application filed is for "compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease".

Company Profile
0.6.7
  • Weavers; Rex T. - Dunedin NZ
  • Weavers; Rex T - Dunedin NZ
  • Weavers; Rex T. - Dundein NZ
  • Weavers; Rex T. - Maryhill NZ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
Grant 8,586,585 - Snow , et al. November 19, 2
2013-11-19
Compounds, Compositions And Methods For The Treatment Of Amyloid Diseases And Synucleinopathies Such As Alzheimer's Disease, Type 2 Diabetes And Parkinson's Disease
App 20120225890 - Snow; Alan D. ;   et al.
2012-09-06
Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
Grant 8,163,957 - Snow , et al. April 24, 2
2012-04-24
Compounds, Compositions and Methods for the Treatment of Amyloid Diseases and Synucleinopathies such as Alzheimer's Disease, Type 2 Diabetes and Parkinson's Disease
App 20110172239 - SNOW; Alan D. ;   et al.
2011-07-14
Substituted N-aryl Benzamides And Related Compounds For Treatment Of Amyloid Diseases And Synucleinopathies
App 20110104055 - Snow; Alan ;   et al.
2011-05-05
Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
Grant 7,763,747 - Snow , et al. July 27, 2
2010-07-27
Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
Grant 7,601,876 - Snow , et al. October 13, 2
2009-10-13
Compounds, Compositions And Methods For The Treatment Of Amyloid Diseases And Synucleinopathies Such As Alzheimer's Disease, Type 2 Diabetes, And Parkinson's Disease
App 20090197965 - Snow; Alan D. ;   et al.
2009-08-06
Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
Grant 7,514,583 - Snow , et al. April 7, 2
2009-04-07
Compounds, Compositions And Methods For The Treatment Of Amyloid Diseases And Synucleinopathies Such As Alzheimer's Disease, Type 2 Diabetes, And Parkinson's Disease
App 20090069432 - Snow; Alan D. ;   et al.
2009-03-12
Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
App 20070225362 - Snow; Alan D. ;   et al.
2007-09-27
Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and parkinson's disease
App 20040127555 - Snow, Alan D. ;   et al.
2004-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed